Jobs
View more job listings or post a job
Gate Bioscience Director of Toxicology
Nura Bio Director of Toxicology
Nura Bio Vice President of CMC
MilliporeSigma Emerging Biotech Market Development Manager - San Fransisco
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Post a job

Workshop

[In-Person] Preclinical Pharmacology Studies and Translational Medicine for Drug Discovery and Development


Speakers: Beth Pysz, AbbVie; Saswata Talukdar, Merck; Dan Xia, Denali; Gundula Min-Oo ,Gilead
Organizers: Anna Zagorska, Gilead; Apurva Chandalia, Biologic Consulting Group
Date: 2025-05-12
Time: 8:45-17:00 Pacific Time
Registration fee: Regular attendees: $295; Academic/Students/Postdocs/Out-of-Pocket: $45; Major Sponsorship: $3000; Vendor Show: $750, Happy Hour Sponsorship: $1250; Lunch Sponsorship: $1500; On-site Registration: $500
Location: Crowne Plaza, Foster City, CA (San Francisco Bay Area)
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2025-05-11  (it will close sooner if the seating cap is reached)

About the Topic

This full-day workshop will provide an overview of animal pharmacology models used in drug development across multiple therapeutic areas. It will be delivered by in vivo pharmacology experts with expertise spanning oncology, autoimmune, neurological, and metabolic diseases. Presentations will include case studies and will aim to deepen participant’s knowledge on how to select a model, design a study, understand model limitations as well as relevance for human disease.

List of topics:

  • In vivo pharmacology fundamentals
  • Overview of commonly used pharmacology models in oncology, autoimmune, metabolic, and neurological diseases
  • Key considerations for model selection including translatability to clinic and target pathway representation.
  • Guidelines for model validation, endpoint selection and study design
  • Animal model utility in supporting clinical development decisions and regulatory filing.


2025-02-06, [In-Person] Intellectual Property (IP) Strategies and Best Practices
2025-02-13, [Free Online] The Science and Stories of Promising Biotech Startups
2025-02-26, [In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
2025-04-01, Seattle PBSS Seminar Luncheon Vendor Show
2025-04-09, [In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)
2025-04-22, [Free Online Workshop] Career Transitions for Research Scientists: BD/Sales in CROs, CDMOs, and Lab Products & Instruments
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
2025-05-05, [Free Online] Highlights of 2024 FDA Drug Approvals
2025-06-02, [In-Person] Metabolism and Transport-mediated Drug-Drug Interaction: Current Practices, Regulatory Guidances, and Their Impact on Drug Development
©Pharmaceutical & BioScience Society, International; Last Modified: 2/5/2025; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Allucent Experts bringing development innovation w/ClinPharm Modeling & Simulation deliverables to inform dose, study design, modeling+development strategies.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Submit a Text Ad